Emerald Advisers’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-115,983
| Closed | -$7.71M | – | 297 |
|
|
2021
Q3 | $7.71M | Sell |
115,983
-268
| -0.2% | -$17.8K | 0.28% | 106 |
|
|
2021
Q2 | $9.07M | Sell |
116,251
-64,257
| -36% | -$5.01M | 0.33% | 104 |
|
|
2021
Q1 | $17.1M | Sell |
180,508
-176,530
| -49% | -$16.7M | 0.62% | 79 |
|
|
2020
Q4 | $43.5M | Buy |
357,038
+58,030
| +19% | +$7.07M | 1.44% | 12 |
|
|
2020
Q3 | $26.1M | Buy |
299,008
+84,699
| +40% | +$7.4M | 1.07% | 32 |
|
|
2020
Q2 | $13.8M | Buy |
214,309
+135,129
| +171% | +$8.73M | 0.6% | 62 |
|
|
2020
Q1 | $3.54M | Buy |
+79,180
| New | +$3.54M | 0.2% | 107 |
|